MoneyWorks4Me

Gennex Laboratories informs about disclosures

10 Jun 2026 Evaluate
Gennex Laboratories has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 10, 2026 for Premier Fiscal Services.

The above information is a part of company’s filings submitted to BSE.  
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..